Home > PS Ratio > WINDLAS BIOTECH

WINDLAS BIOTECH
PS (Price/Sales) Ratio

The Current P/S Ratio of WINDLAS BIOTECH is 1.91.

Share Price ₹549.9Apr 25,2024
Market Cap ₹1,143.8 Cr
Sales-TTM₹600.4 CrTTM-Consolidated Results
Price/Sales1.91xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of WINDLAS BIOTECH

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of WINDLAS BIOTECH is calculated as :

Current Market Cap [ ₹1,143.8 Cr] as on Apr 25,2024

(/) Sales [ ₹600.4 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 1.91x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '1.91 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of WINDLAS BIOTECH !

The chart below summarizes the trend in P/S Ratio of WINDLAS BIOTECH over the last five years.

Historical PS (Price/Sales) ratio chart of WINDLAS BIOTECH


PS Ratio Performance Analysis for WINDLAS BIOTECH

- WINDLAS BIOTECH 's latest p/e ratio is 1.91x.

- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.38x.

- WINDLAS BIOTECH 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2022 at 0.98x.

- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.


How does WINDLAS BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
WINDLAS BIOTECH 600.41.911,143.8
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.69364,831.0
CIPLA LTD25,350.24.48113,471.0
DR REDDYS LABORATORIES LTD27,212.53.81103,713.0
ZYDUS LIFESCIENCES LTD19,024.25.0395,687.8
DIVIS LABORATORIES LTD7,492.813.61101,960.0
MANKIND PHARMA LTD9,946.39.6696,093.1
TORRENT PHARMACEUTICALS LTD10,474.08.7091,124.7
LUPIN LTD19,480.13.7372,687.6
AUROBINDO PHARMA LTD27,894.72.3264,661.3
ABBOTT INDIA LTD5,753.49.4854,533.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WINDLAS BIOTECH 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.91x
Max industry PS 13.61x
Median industry PS 5.03x
Average industry PS 6.40x



You may also like the below Video Courses